Literature DB >> 8420827

T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome.

Y Fukui1, Y Esaki, A Kimura, K Hirokawa, Y Nishimura, T Sasazuki.   

Abstract

We have established a strain of transgenic mice in which the HLA-DRA gene was integrated into the X-chromosome and the xenogeneic mixed isotype molecule, DR alpha E beta b, was expressed in a cell type-specific manner, although the transgenic DRA gene contained only 268 base pairs of the 5'-flanking region. The DR alpha E beta b molecules expressed in the transgenic mice functioned as major histocompatibility complex (MHC) class II to select T-cell repertoire, and to stimulate mixed lymphocyte reaction. In female transgenic mice homozygous for HLA-DRA (DR alpha-B6-F-homo) and male transgenic mice (DR alpha-B6-M), DR alpha E beta b molecules were expressed in almost all of the MHC class II Ab-positive cells. In contrast, the expression of DR alpha E beta b molecules in female transgenic mice hemizygous for HLA-DRA (DR alpha-B6-F-hemi) was found only in part of the Ab positive cells, and the proportion of cells expressing the DR alpha E beta b molecules varied due to random inactivation of one of the X-chromosomes. Clonal deletions of the T cells and mature thymocytes bearing Tcrb-V5 and Tcrb-V11, which are eliminated from the peripheral repertoire in mice expressing self-superantigen and MHC class II E molecules, were incomplete in DR alpha-B6-F-hemi as compared with those in DR alpha-B6-F-homo, and were correlated with the proportion of DR alpha E beta b-positive spleen cells. These observations suggested that the number of bone marrow-derived cells expressing DR alpha E beta b molecules was critical for clonal deletions of Tcrb-V5+ and Tcrb-V11+ T cells in the thymus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420827     DOI: 10.1007/bf00191886

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  31 in total

1.  Different recognition of transgenic HLA-DQw6 molecules by mouse CD4+ and CD8+ T cells.

Authors:  T Inamitsu; Y Nishimura; T Sasazuki
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Tissue-specific expression of the HLA-DRA gene in transgenic mice.

Authors:  P Giacomini; A Ciucci; M R Nicotra; C Nastruzzi; G Feriotto; E Appella; R Gambari; L Pozzi; P G Natali
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  T-cell receptor-specific monoclonal antibodies against a V beta 11-positive mouse T-cell clone.

Authors:  K Tomonari; E Lovering
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.

Authors:  M Crowley; K Inaba; M Witmer-Pack; R M Steinman
Journal:  Cell Immunol       Date:  1989-01       Impact factor: 4.868

6.  Functional expression of a microinjected Ed alpha gene in C57BL/6 transgenic mice.

Authors:  K Yamamura; H Kikutani; V Folsom; L K Clayton; M Kimoto; S Akira; S Kashiwamura; S Tonegawa; T Kishimoto
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

7.  Timing of X-chromosome inactivation in postimplantation mouse embryos.

Authors:  S Rastan
Journal:  J Embryol Exp Morphol       Date:  1982-10

8.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Monoclonal antibody against an Ir gene product?

Authors:  E A Lerner; L A Matis; C A Janeway; P P Jones; R H Schwartz; D B Murphy
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus.

Authors:  O Mazda; Y Watanabe; J Gyotoku; Y Katsura
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  6 in total

1.  Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.

Authors:  K Kawamura; T Yamamura; K Yokoyama; D H Chui; Y Fukui; T Sasazuki; H Inoko; C S David; T Tabira
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein.

Authors:  Y Esaki; Y Fukui; T Sudo; K Yamamoto; T Inamitsu; Y Nishimura; K Hirokawa; A Kimura; T Sasazuki
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

3.  Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.

Authors:  K Yamamoto; Y Fukui; Y Esaki; T Inamitsu; T Sudo; K Yamane; N Kamikawaji; A Kimura; T Sasazuki
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

4.  The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4.

Authors:  D M Altmann; D C Douek; A J Frater; C M Hetherington; H Inoko; J I Elliott
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

5.  Generating a transgenic mouse line stably expressing human MHC surface antigen from a HAC carrying multiple genomic BACs.

Authors:  Yoshinori Hasegawa; Tomoyuki Ishikura; Takanori Hasegawa; Takashi Watanabe; Junpei Suzuki; Manabu Nakayama; Yoshiaki Okamura; Tuneko Okazaki; Haruhiko Koseki; Osamu Ohara; Masashi Ikeno; Hiroshi Masumoto
Journal:  Chromosoma       Date:  2014-10-12       Impact factor: 4.316

6.  Trace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation.

Authors:  Antoine Ménoret; Julia Svedova; Bharat Behl; Anthony T Vella
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.